Journal: Journal of Cancer
Article Title: UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma
doi: 10.7150/jca.92473
Figure Lengend Snippet: Correlation between cell cycle and apoptosis related genes and UBE2C in LUAD. (A) Correlation between mRNA expression of cell cycle and apoptosis related genes and UBE2C based on GEPIA2 database. (B) Differential protein expression of cell cycle and apoptosis-related genes in LUAD compared with normal lung tissue. (C) After silencing UBE2C, the expression levels of CDK1/2, CASP3, PCNA, MCM4, MCM2, MCM6, MCM7, LMNB2, DFFA, MAP2K2 and TRADD in both NCI-H1299 and A549 cells ( # p >0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).
Article Snippet: Antibodies used in our study included anti-UBE2C (1:2000; ab125002), anti-human β-actin (1:1000, #4970; Cell Signaling Technology, Danvers, MA, USA), anti-p-AKT (1:1000; CST4060), anti-AKT (1:1000; CST4691), anti-p-mTOR (1:1000; CST5536), anti-mTOR (1:1000; CST2972), CDK1/2 (AN21.2, Santa Cruz Biotechnology, sc-53219), PCNA (PC10, Santa Cruz Biotechnology, sc-56), MCM2 (E-8, Santa Cruz Biotechnology, sc-373702), MCM4(G-7, Santa Cruz Biotechnology, sc-28317), MCM6 (H-8, Santa Cruz Biotechnology, sc-393618), MCM7 (141.2, Santa Cruz Biotechnology, sc-9966), CASP3(caspase-3, 31A1067, Santa Cruz Biotechnology, sc-56053), DFFA (LCAD, F-8, Santa Cruz Biotechnology, sc-17816), MAP2K2 (A-1, Santa Cruz Biotechnology, sc-13159), LMNB2 (F-8, Santa Cruz Biotechnology, sc-377379), TRADD (A-5, Santa Cruz Biotechnology, sc-46653) and anti-rabbit IgG (1:1000; #7074, Cell Signaling Technology).
Techniques: Expressing